MSN Laboratories Private Limited — Imatinib Exporter Profile
Indian Pharmaceutical Exporter · #12 for Imatinib · $219.5K export value · DGFT Verified
MSN Laboratories Private Limited is the #12 Indian exporter of Imatinib with $219.5K in export value and 13 verified shipments. MSN Laboratories Private Limited holds a 0.7% market share in Imatinib exports across 3 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Imatinib Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Imatinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| INDONESIA | $168.2K | 11 | 77.1% |
| PERU | $50.0K | 1 | 22.9% |
| JORDAN | $0 | 1 | 0.0% |
MSN Laboratories Private Limited exports Imatinib to 3 countries. The largest destination is INDONESIA accounting for 77.1% of MSN Laboratories Private Limited's Imatinib shipments, followed by PERU (22.9%) and JORDAN (0.0%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Imatinib from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PT MEGA LIFESCIENCES INDONESIA | INDONESIA | $69.3K | 2 |
| MSN LABS PERU SAC | PERU | $50.0K | 1 |
| TO THE ORDER OF | INDONESIA | $47.7K | 2 |
| TO THE ORDER OF., | INDONESIA | $29.2K | 2 |
| TO THE ORDER PT MEGA LIFESCIENCES INDONESIA GEDUNG | INDONESIA | $18.0K | 4 |
| 'TO THE ORDER | INDONESIA | $4.0K | 1 |
| AL-HILAL DRUG STORE ABU-LAIL COMMERCIAL COMPLEX BUILDING | JORDAN | $0 | 1 |
MSN Laboratories Private Limited supplies Imatinib to 7 buyers globally. The largest buyer is PT MEGA LIFESCIENCES INDONESIA (INDONESIA), followed by MSN LABS PERU SAC (PERU) and TO THE ORDER OF (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Imatinib Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $18.5M worth of Imatinib through 1,726 shipments from 224 suppliers to 119 countries, serving 456 buyers globally. MSN Laboratories Private Limited contributes $219.5K to this total, accounting for 0.7% of India's Imatinib exports. MSN Laboratories Private Limited ships Imatinib to 3 countries through 7 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Imatinib Exports?
MSN Laboratories Private Limited's average Imatinib shipment value is $16.9K per consignment, based on 13 shipments totaling $219.5K. The largest destination is INDONESIA (77.1% of MSN Laboratories Private Limited's Imatinib exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Imatinib Exporters?
MSN Laboratories Private Limited ranks #12 among 224 Indian Imatinib exporters with a 0.7% market share. The top 3 exporters are CIPLA LIMITED ($5.2M), EUGIA PHARMA SPECIALITIES LIMITED ($4.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.9M). MSN Laboratories Private Limited processed 13 shipments to 3 destination countries.
What Imatinib Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TYKONIB 100 MG (IMATINIB MESYLATE TABLETS)3X10 S | $69.3K | 2 |
| TYKONIB 400 (IMATINIB 3X10) -PENOS | $50.0K | 1 |
| MSN PHARMACEUTICAL PRODUCT NAME TYKONIB400 IMATINIB MESYLATE TABLETS MG 3X10S | $29.9K | 1 |
| MSN LABS, TYKONIB 400MG (IMATINIB MESYLA | $20.4K | 1 |
| MSN PHARMACEUTICAL PRODUCT NAME : TYKONIB 100MG IMATINIB MESYLATE TABLETS3X10'S | $18.0K | 4 |
| MSN PHARMACEUTICAL PRODUCT NAME TYKONIB100 IMATINIB MESYLATE TABLETS MG 3X10S | $17.9K | 1 |
| MSN LABS, TYKONIB 100MG (IMATINIB MESYLA | $8.8K | 1 |
| TYKONIB 100 MG(IMATINIB MESYLATE TABLETS | $4.0K | 1 |
| IMATINIB REFERENCE STANDARD | $0 | 1 |
MSN Laboratories Private Limited exports 9 distinct Imatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TYKONIB 100 MG (IMATINIB MESYLATE TABLETS)3X10 S with 2 shipments worth $69.3K.
How Does MSN Laboratories Private Limited Compare to Nearest Imatinib Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | INTAS PHARMACEUTICALS LTD | $284.7K | 8 | 5 | $35.6K |
| 11 | VHB MEDISCIENCES LTD | $250.6K | 9 | 1 | $27.8K |
| 12 | MSN LABORATORIES PRIVATE LIMITED ★ | $219.5K | 13 | 3 | $16.9K |
| 13 | VEXXA LIFESCIENCES PVT. LTD. | $204.3K | 57 | 2 | $3.6K |
| 10 | DR REDDYS LABORATORIES LIMITED | $200.0K | 4 | 3 | $50.0K |
MSN Laboratories Private Limited ranks #12 among 224 Indian Imatinib exporters. Average shipment value of $16.9K compared to the market average of $82.5K. The closest competitors by value are INTAS PHARMACEUTICALS LTD and VHB MEDISCIENCES LTD.
Which Indian Ports Ship Imatinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 314 | 18.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 17.4% |
| DELHI AIR CARGO ACC (INDEL4) | 235 | 13.6% |
| DELHI AIR | 142 | 8.2% |
| Bombay Air | 123 | 7.1% |
| HYDERABAD AIR | 69 | 4.0% |
| HYDERABAD ACC (INHYD4) | 61 | 3.5% |
| AHEMDABAD AIR | 35 | 2.0% |
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Imatinib Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Imatinib, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching MSN Laboratories Private Limited exporting Imatinib, covering 9 formulations to 3 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Imatinib Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Imatinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Imatinib Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imatinib. For current shipment-level data, contact TransData Nexus.